DIH Holding US (DHAI) Competitors $0.24 -0.01 (-3.11%) Closing price 07/3/2025 03:49 PM EasternExtended Trading$0.24 0.00 (-1.25%) As of 07/3/2025 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DHAI vs. NEPH, SPAI, MODD, ECOR, POCI, QTI, PYPD, NMTC, TMDIF, and COCHShould you be buying DIH Holding US stock or one of its competitors? The main competitors of DIH Holding US include Nephros (NEPH), Safe Pro Group (SPAI), Modular Medical (MODD), electroCore (ECOR), Precision Optics (POCI), QT Imaging (QTI), PolyPid (PYPD), NeuroOne Medical Technologies (NMTC), Titan Medical (TMDIF), and Envoy Medical (COCH). These companies are all part of the "medical equipment" industry. DIH Holding US vs. Its Competitors Nephros Safe Pro Group Modular Medical electroCore Precision Optics QT Imaging PolyPid NeuroOne Medical Technologies Titan Medical Envoy Medical DIH Holding US (NASDAQ:DHAI) and Nephros (NASDAQ:NEPH) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment. Is DHAI or NEPH more profitable? Nephros has a net margin of 5.16% compared to DIH Holding US's net margin of -13.59%. Nephros' return on equity of 9.43% beat DIH Holding US's return on equity.Company Net Margins Return on Equity Return on Assets DIH Holding US-13.59% N/A -25.97% Nephros 5.16%9.43%7.20% Which has more risk & volatility, DHAI or NEPH? DIH Holding US has a beta of 0.07, meaning that its stock price is 93% less volatile than the S&P 500. Comparatively, Nephros has a beta of 1.09, meaning that its stock price is 9% more volatile than the S&P 500. Do institutionals & insiders hold more shares of DHAI or NEPH? 27.8% of DIH Holding US shares are held by institutional investors. Comparatively, 41.1% of Nephros shares are held by institutional investors. 49.6% of DIH Holding US shares are held by company insiders. Comparatively, 6.7% of Nephros shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media prefer DHAI or NEPH? In the previous week, DIH Holding US and DIH Holding US both had 1 articles in the media. DIH Holding US's average media sentiment score of 0.00 equaled Nephros'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DIH Holding US 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nephros 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher earnings & valuation, DHAI or NEPH? Nephros has lower revenue, but higher earnings than DIH Holding US. DIH Holding US is trading at a lower price-to-earnings ratio than Nephros, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDIH Holding US$64.47M0.18-$8.44M-$0.30-0.80Nephros$14.16M3.05$70K$0.0758.29 Do analysts rate DHAI or NEPH? Nephros has a consensus target price of $5.00, suggesting a potential upside of 22.55%. Given Nephros' stronger consensus rating and higher possible upside, analysts plainly believe Nephros is more favorable than DIH Holding US.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DIH Holding US 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Nephros 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryNephros beats DIH Holding US on 12 of the 14 factors compared between the two stocks. Get DIH Holding US News Delivered to You Automatically Sign up to receive the latest news and ratings for DHAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DHAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DHAI vs. The Competition Export to ExcelMetricDIH Holding USTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$11.08M$2.42B$13.16B$9.05BDividend YieldN/A1.37%2.54%4.01%P/E Ratio-0.8013.5624.8120.21Price / Sales0.1836.6140.58119.02Price / CashN/A43.9226.8358.10Price / Book-0.305.876.295.67Net Income-$8.44M$32.32M$188.91M$249.21M7 Day Performance-4.38%5.99%3.69%3.28%1 Month Performance5.63%8.22%4.72%5.55%1 Year Performance-92.05%58.94%38.85%21.09% DIH Holding US Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DHAIDIH Holding US0.6733 of 5 stars$0.24-3.1%N/A-92.1%$11.08M$64.47M-0.80N/AGap DownNEPHNephros0.8654 of 5 stars$4.03-1.5%$5.00+24.1%+96.6%$43.35M$14.16M57.5830News CoveragePositive NewsGap DownHigh Trading VolumeSPAISafe Pro GroupN/A$2.63-4.4%N/AN/A$41.72M$2.17M-3.2511Positive NewsGap DownMODDModular MedicalN/A$0.71-4.9%N/A-47.9%$40.41MN/A-1.3920ECORelectroCore2.3451 of 5 stars$5.24-0.8%$25.50+386.6%-3.5%$39.18M$25.18M-3.3650POCIPrecision OpticsN/A$4.92+0.4%N/A-22.3%$37.56M$19.10M-5.5380QTIQT ImagingN/A$1.33-4.1%N/A+89.5%$36.16M$4.00M0.00N/ANews CoverageGap DownPYPDPolyPid2.1117 of 5 stars$3.53flat$11.80+234.3%-12.8%$35.97MN/A-0.8280NMTCNeuroOne Medical Technologies2.2374 of 5 stars$0.70+3.2%$1.45+107.1%-15.9%$33.79M$3.45M-3.1820TMDIFTitan MedicalN/A$0.27-4.9%N/A+675.6%$31.02M$17.63M-0.2250Gap DownCOCHEnvoy Medical2.8106 of 5 stars$1.49+4.9%$9.25+520.8%-32.4%$30.28M$220K-1.0834News Coverage Related Companies and Tools Related Companies Nephros Alternatives Safe Pro Group Alternatives Modular Medical Alternatives electroCore Alternatives Precision Optics Alternatives QT Imaging Alternatives PolyPid Alternatives NeuroOne Medical Technologies Alternatives Titan Medical Alternatives Envoy Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DHAI) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DIH Holding US, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DIH Holding US With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
